ライフサイエンスコーパス: surface glycoprotein

1 infectivity by binding to the E2 (envelope) surface glycoprotein.

2 Clr-a as a disulfide-linked homodimeric cell surface glycoprotein.

3 tive metacyclic forms expressing the variant surface glycoprotein.

4 receptor-binding site on the haemagglutinin surface glycoprotein.

5 osomes, of pre-existing cell surface variant surface glycoprotein.

6 quence changes in the V3 region of the gp120 surface glycoprotein.

7 hatidylinositol-anchored (GPI-anchored) cell surface glycoprotein.

8 e third hypervariable (V3) loop of the HIV-1 surface glycoprotein.

9 contained mutations in the hr1 region of the surface glycoprotein.

10 on CTLs may be linked to reduced motility of surface glycoproteins.

11 rated into O-GlcNAcylated proteins over cell-surface glycoproteins.

12 e trafficking, activity, and localization of surface glycoproteins.

13 g, corroborating an increase in high mannose surface glycoproteins.

14 well-characterized antigenic changes in the surface glycoproteins.

15 ,6GlcNAc-branched N-glycans attached to cell surface glycoproteins.

16 masking glycan ligands on midgut epithelial surface glycoproteins.

17 ot motif found in multisubunit external cell surface glycoproteins.

18 rus (VSV) or Ross River virus (RRV) envelope surface glycoproteins.

19 ed alpha2,3 or alpha2,6 sialic acids on cell surface glycoproteins.

20 Here we report that CTB binds cell surface glycoproteins.

21 binding to terminally sialylated glycans on surface glycoproteins.

22 ee new anti-HIV aptamers targeting the viral surface glycoprotein 120 (gp120) were selected, synthesi

23 ntitrypanosomal drug, suramin, via invariant surface glycoprotein 75, and in the uptake of trypanosom

24 ce proteomes, being dominated by the variant surface glycoprotein (African) or mucins (American) resp

25 orption of an antibody specific for a virion surface glycoprotein allowed differentiation of MCMV fro

26 quence) gene family encodes eight large cell-surface glycoproteins (Als1-Als7 and Als9) that have adh

27 cyclophilin C or rotamase) to the CD147 cell surface glycoprotein (also known as extracellular matrix

28 orchestrated via the concerted action of two surface glycoproteins: an attachment protein called hema

29 t stage, enabling rapid recycling of variant surface glycoprotein and antibody clearance from the sur

30 The RSV F protein is a highly conserved surface glycoprotein and is the main target of neutraliz

31 the hemagglutinin (HA) or neuraminidase (NA) surface glycoprotein and other influenza virus proteins.

32 ding the major cell surface antigens variant surface glycoprotein and procyclin.

33 rophobic helical structures, from the HCV E2 surface glycoprotein and the CD81 protein, a major host

34 Many viral surface glycoproteins and cell surface receptors are hom

35 any cellular processes by oligomerizing cell surface glycoproteins and glycolipids into higher-order

36 iversity, and selection pressure between the surface glycoproteins and internal gene segments of avia

37 cine include the variability of the envelope surface glycoproteins and its high-density glycan shield

38 anism for regulation of the activity of cell-surface glycoproteins and likely contributes to maintena

39 ptamer conjugates against two different cell surface glycoproteins and show that these reagents are a

40 irulence and express the VEEV and EEEV E2/E1 surface glycoproteins as vaccine antigens.

41 nd #10 antibodies can be used to detect cell surface glycoproteins bearing O-GlcNAc.

42 to date have incorporated the RSV fusion (F) surface glycoprotein, because the sequence of F is highl

43 These polymorphic cell-surface glycoproteins bind peptide antigens, forming lig

44 GPIHBP1, an endothelial cell-surface glycoprotein, binds LPL and is required for the

45 nveloped viruses often require cleavage of a surface glycoprotein by a cellular endoprotease such as

46 Galectin-3 (Gal-3) can cross-link surface glycoproteins by binding galactose residues that

47 We reported that removing a specific set of surface glycoproteins by ex vivo treatment with O-sialog

48 We demonstrate that S1 is a cell surface glycoprotein capable of binding to host SLAMF6.

49 The cell-surface glycoprotein CD44 is expressed in chronic lympho

50 The cell surface glycoprotein CD44 plays an important role in the

51 n MSC expression of the multifunctional cell surface glycoprotein CD44, a putative stem cell marker.

52 Previous studies have implicated the surface glycoproteins CD44 and carcinoembryonic antigen

53 ding bovine submaxillary mucin and leukocyte surface glycoproteins CD45 and P-selectin glycoprotein l

54 Here, we investigated whether the cell surface glycoprotein CD47 was required for normal format

55 The T cell-surface glycoprotein CD6 is a modulator of cellular resp

56 We report that the surface glycoprotein CD62L can be characterized as a nov

57 We have identified the cell surface glycoprotein CDCP1 as a key regulator of EGF/EGF

58 hell in a rationally arranged fashion with a surface glycoprotein coated on to the surface and non-st

59 the viral polymerases and the hemagglutinin surface glycoprotein conferred respiratory droplet trans

60 The surface glycoprotein contains a free cysteine at residue

61 ly active isoforms: a membrane-spanning cell surface glycoprotein (csCSF-1), a secreted proteoglycan

62 Regions within the HCV surface glycoproteins E1 and E2 are essential for virus

63 the lack of structural information about its surface glycoproteins E1 and E2, the two constituents of

64 HCV is an enveloped virus with two surface glycoproteins (E1 and E2).

65 Antibodies targeting the Ebola virus surface glycoprotein (EBOV GP) are implicated in protect

66 the procyclic form caused underglycosylated surface glycoprotein EP-procyclin.

67 ei results in derepression of silent variant surface glycoprotein ESs, as had previously been shown f

68 that is driven primarily by soluble variant surface glycoprotein exposure, and it may be that IFN-al

69 cell adhesion molecule (EpCAM) (CD326) is a surface glycoprotein expressed by invasive carcinomas an

70 ly protein basigin (EMMPRIN/CD147) is a cell surface glycoprotein expressed by tumor cells that stimu

71 cell adhesion molecule-2 (CEACAM2) is a cell-surface glycoprotein expressed on blood, epithelial, and

72 BAI1 (termed Vstat120) requires CD36, a cell surface glycoprotein expressed on microvascular endothel

73 uences the choice of a monocistronic variant surface glycoprotein expression site.

74 crothrombocytopenic and had reduced platelet surface glycoprotein expression, including GPVI, alphaII

75 osynthesis of DG core protein or global cell surface glycoprotein expression.

76 condly, knockdown of clathrin or the variant surface glycoprotein failed to perturb transcription.

77 rculating antibodies against the Ebola virus surface glycoprotein for more than a decade after infect

78 s in GNE activity can alter affinity of cell-surface glycoproteins for the galectin lattice.

79 s bind GlcNAc-branched N-glycans attached to surface glycoproteins, forming a molecular lattice that

80 The variable surface glycoprotein from African Trypanosomes was chose

81 clonal antibodies using a set of recombinant surface glycoproteins from Reston, Tai Forest, Bundibugy

82 Understanding how the Ebola virus surface glycoprotein functions to facilitate entry in ce

83 pseudotyped with vesicular stomatitis virus surface glycoprotein G (VSV-G).

84 The virus surface glycoprotein (G) has been shown to direct BDV ce

85 BDV surface glycoprotein (G) plays a critical role in virus

86 the Rhabdoviridae family, contains a single surface glycoprotein (G) that is responsible for attachm

87 endocytosis, a process mediated by the virus surface glycoprotein (G), but the cellular factors and p

88 fied receptor at the cell surface by the BDV surface glycoprotein (G).

89 The cell surface glycoprotein gamma-glutamyl transpeptidase (GGT)

90 ted a monoclonal antibody raised against CMV surface glycoprotein (gB) with gold nanoparticles (GNP)

91 VSV) vector backbone that lacks the native G surface glycoprotein gene (VSVDeltaG).

92 ar stomatitis virus (serotype Indiana) whose surface glycoprotein gene was replaced by the Zaire Ebol

93 With the identification of surface glycoprotein genes adjacent to telomeres in the

94 elomeric regions rich in life-stage-specific surface glycoprotein genes involved in pathogenesis.

95 anosome relies upon the silencing of variant surface glycoprotein genes that are found adjacent to te

96 criptional switching of subtelomeric variant surface glycoprotein genes, continues to operate indepen

97 d involves switches in expression of variant surface glycoprotein genes, which are co-transcribed wit

98 ere identified using antibodies against ANDV surface glycoproteins Gn and Gc to competitively elute a

99 Synthesis of the surface glycoprotein GP of Ebola virus (EBOV) is depende

100 s expressing the Ebola virus (Zaire species) surface glycoprotein (GP) alone or in combination with t

101 Synthesis of Ebola virus (EBOV) surface glycoprotein (GP) is dependent on transcriptiona

102 The surface glycoprotein (GP) is responsible for Ebola virus

103 monoclonal antibodies (MAbs) that target the surface glycoprotein (GP) of Ebola virus (EBOV) are effe

104 Ebola virus (EBOV) entry requires the surface glycoprotein (GP) to initiate attachment and fus

105 In addition to its surface glycoprotein (GP), Ebola virus directs the produ

106 a proinflammatory signature triggered by the surface glycoprotein (GP), which can be inhibited by blo

107 s the transmembrane-anchored, trimeric viral surface glycoprotein (GP).

108 The Ebola virus (EBOV) surface glycoprotein (GP1,2) mediates host cell attachme

109 The EBOV surface glycoprotein (GP1,2) plays important roles in vi

110 Ebolaviruses have a surface glycoprotein (GP1,2) that is required for virus

111 two amino acid changes, one within the virus surface glycoprotein (GP1: F260L) and the other within t

112 cleaved by cellular proteases to the mature surface glycoprotein gp120 and the transmembrane glycopr

113 The HIV-1 surface glycoprotein gp120 has been reported to bind and

114 hly variable and immunogenic region of HIV-1 surface glycoprotein gp120, and structural information a

115 A hollow (Phe43 cavity) between HIV-1 surface glycoprotein (gp120) and cluster of differentiat

116 Previous work has demonstrated that the surface glycoprotein (gp120) of human immunodeficiency v

117 of a transmembrane glycoprotein (gp41) and a surface glycoprotein (gp120), and forms trimers on the s

118 of a transmembrane glycoprotein (gp41) and a surface glycoprotein (gp120).

119 imeric complex of heterodimers composed of a surface glycoprotein, gp120, and a transmembrane compone

120 telet storage lesion, is the shedding of the surface glycoproteins GPIb-alpha and GPV.

121 pathogenic and nonpathogenic members, whose surface glycoproteins (GPs) are characterized by differe

122 The Streptococcus gordonii cell surface glycoprotein GspB mediates high-affinity binding

123 Abnormal expression of TACSTD2 cell-surface glycoprotein has been reported in most epithelia

124 Each Sindbis virus (SINV) surface glycoprotein has two sites for N-linked glycosyl

125 GPI membrane anchors of cell surface glycoproteins have been shown to confer function

126 Influenza C viruses have only one major surface glycoprotein, HEF (hemagglutinin-esterase fusion

127 s and detailed molecular mechanisms of viral surface glycoprotein hemagglutinin (HA) binding with a b

128 The influenza surface glycoprotein hemagglutinin (HA) is a potential t

129 o induce neutralizing antibodies against the surface glycoprotein hemagglutinin (HA) is the primary m

130 ified amino acids in antigenic site B of the surface glycoprotein hemagglutinin (HA) that explain the

131 nic properties are largely determined by the surface glycoprotein hemagglutinin (HA), and amino acid

132 n occurs through the binding formed by viral surface glycoprotein hemagglutinin and certain types of

133 differences, which generally agreed with the surface glycoprotein hemagglutinin esterase phylogeny, w

134 us and have been licensed for human use, the surface glycoproteins hemagglutinin (HA) and neuraminida

135 s with the cell surface is controlled by the surface glycoproteins hemagglutinin (HA) and neuraminida

136 l-mediated immunity, often against the viral surface glycoproteins hemagglutinin (HA) and neuraminida

137 e transmissibility is the interaction of the surface glycoproteins hemagglutinin (HA) and neuraminida

138 luenza virus induces antibodies to the viral surface glycoproteins hemagglutinin and neuraminidase, a

139 Alterations in the viral surface glycoprotein, hemagglutinin (HA), typically are

140 This study focuses on the major surface glycoprotein hemagglutinins from both of these n

141 ody responses against the hemagglutinin (HA) surface glycoprotein; however, the diversity of HAs acro

142 infectious virus in the absence of their own surface glycoprotein if a suitable glycoprotein from a f

143 Mucin-4 (Muc4) is a large cell surface glycoprotein implicated in the protection and lu

144 mulated with the trypanosome soluble variant surface glycoprotein in vitro and in macrophages taken f

145 le NST gene results in measurable defects in surface glycoproteins in different life cycle stages of

146 this question, we profiled the abundance of surface glycoproteins in WT and CRISPR-mediated GNPTAB(-

147 Galectin-3 binding to cell surface glycoproteins, including branched N-glycans gene

148 ect expression and functions of CD44, a cell-surface glycoprotein influencing immunologic, inflammato

149 ring with the endocytic transport of variant surface glycoprotein is a highly desirable strategy for

150 an EBOV vaccine candidate in which the viral surface glycoprotein is biomanufactured as a fusion to a

151 A bloodstream stage-specific invariant surface glycoprotein (ISG75) family mediates suramin upt

152 The propinquity of CD22 and cell-surface glycoprotein ligands has led to the conclusion t

153 ies maintained a similar organization of the surface glycoproteins, matrix protein (M), M2-1, and the

154 nsional density maps show how the hantavirus surface glycoproteins, membrane, and ribonucleoprotein a

155 essing the hepatitis B virus middle envelope surface glycoprotein (MS) that induces strong MS-specifi

156 ic responses to Pneumocystis jirovecii major surface glycoprotein (Msg) antigen in African cohorts, o

157 ne responses to Pneumocystis jirovecii major surface glycoprotein (Msg) in individuals with human imm

158 acilitating switching of the expressed major surface glycoprotein (Msg) variant.

159 The major surface glycoprotein (Msg), which is the most abundant p

160 multicopy gene family that encodes the major surface glycoprotein (Msg).

161 t fragments that span the P. jirovecii major surface glycoprotein: MsgA (amino terminus), MsgB (middl

162 The cell-surface glycoprotein MUC1 is a particularly appealing ta

163 Cell surface glycoprotein MUC18 (alias CD146 or melanoma cell

164 homophilic interaction mediated by the cell surface glycoprotein MUC18 (also known as melanoma cell

165 principal target for these drugs is a virus surface glycoprotein, neuraminidase, which facilitates t

166 cosylation of HA and the other two major IAV surface glycoproteins, neuraminidase (NA) and M2 ion cha

167 sion of the hemagglutinin-neuraminidase (HN) surface glycoprotein of human parainfluenza virus type 3

168 richia coli was able to solubilize the major surface glycoprotein of Pneumocystis, thus potentially f

169 Drosophila basigin is a cell-surface glycoprotein of the Ig superfamily and a member

170 Emmprin (CD147; basigin) is a cell surface glycoprotein of the immunoglobulin superfamily t

171 The major surface glycoprotein of the procyclic form, the procycli

172 stomatitis virus-based vaccine expressing a surface glycoprotein of Zaire Ebolavirus (rVSV-ZEBOV) is

173 ee adenovirus 3 (ChAd3) vaccine encoding the surface glycoprotein of Zaire ebolavirus (ZEBOV) to 60 h

174 s virus-based candidate vaccine expressing a surface glycoprotein of Zaire Ebolavirus.

175 These results indicate that the surface glycoproteins of batMuV are serologically and fu

176 of a highly conserved family of serine-rich surface glycoproteins of gram-positive bacteria.

177 al basis of the interaction of the two major surface glycoproteins of influenza A virus with their co

178 (NA) is a sialidase that is one of the major surface glycoproteins of influenza A viruses and the tar

179 on of newly synthesized GPI-anchored variant surface glycoprotein on the cell surface.

180 Mass spectrometry of total surface glycoproteins on platelets isolated from wild-ty

181 ect energy utilization and synthesis of cell-surface glycoproteins or glycolipids involved in cell mo

182 tope on O-glycans linked to a leukocyte cell-surface glycoprotein, P-selectin Glycoprotein Ligand-1 (

183 requires the virus RING finger Z protein and surface glycoprotein precursor (GPC) and the correct pro

184 P) of the lymphocytic choriomeningitis virus surface glycoprotein precursor has several unique charac

185 ife cycle, beyond translocation of the viral surface glycoprotein precursor into the endoplasmic reti

186 timulated by direct Gal-1 engagement to cell surface glycoproteins, principally CD45, on activated Th

187 ent methods are required for the analysis of surface glycoproteins prior to MS measurement.

188 The hemagglutinin (HA) surface glycoprotein promotes influenza virus entry and

189 tain the cell density of its crucial variant surface glycoprotein protective coat.

190 CPD of the ORFs for the G and F surface glycoproteins provided the greatest restrictive

191 L) cells express high levels of CD44, a cell-surface glycoprotein receptor for hyaluronic acid.

192 Here, we report the structure of the JUNV surface glycoprotein receptor-binding subunit (GP1) boun

193 In this study, we explore the role of surface glycoprotein receptors and signaling proteins in

194 vanced glycation end-products and other cell surface glycoprotein receptors on MDSC, signal through t

195 Cell surface glycoproteins recognized by CTD110.6 antibody in

196 The epitopes of the Lassa virus (LASV) surface glycoproteins recognized by naturally infected h

197 MHC-encoded butyrophilin, BTN2A1, is a cell surface glycoprotein related to the extended family of B

198 Influenza hemagglutinin is a surface glycoprotein related to virus invasion and host

199 Tissue factor (TF) is a cell-surface glycoprotein responsible for initiating the coag

200 nv) and influenza hemagglutinin (HA) are the surface glycoproteins responsible for viral entry into h

201 ins and the glycan ligands presented on cell surface glycoproteins results in high-avidity binding th

202 of entry of HIV-1 pseudotyped with SARS-CoV surface glycoprotein S (SARS-S) but not that of HIV-1 ps

203 ainst axonal guidance cues, such as the cell surface glycoproteins Semaphorin 1a (Sema 1a) and Fascic

204 RPs, when administered intranasally, induced surface glycoprotein-specific virus neutralizing antibod

205 class I-related chain A (MICA) antigens are surface glycoproteins strongly implicated in innate immu

206 rom the FeLV-A prototype, FeLV-A/61E, in the surface glycoprotein (SU) and long terminal repeat (LTR)

207 We observed that HTLV-3 surface glycoprotein (SU) binds efficiently to both acti

208 Furthermore, the ratios of surface glycoprotein (SU) to capsid protein (CA) in the

209 A strong antiviral response to the viral surface glycoprotein (SU) was noted in both natural and

210 tions and, therefore, reduce the motility of surface glycoproteins, such as the T-cell receptor.

211 ce proteins, especially a unique and complex surface glycoprotein superfamily, as well as proteases a

212 c sugar composition of the parasites variant surface glycoprotein synthesized in cells incubated in 5

213 glycosyl phosphatidylinositol-anchored cell surface glycoprotein T-cadherin (encoded by Cdh13) prote

214 Alpha-dystroglycan (alpha-DG) is a cell-surface glycoprotein that acts as a receptor for both ex

215 Glypican-3 is a cell surface glycoprotein that associates with Wnt in liver c

216 B, type I (SR-BI), is a homooligomeric cell surface glycoprotein that controls HDL structure and met

217 ound that antibodies to glycoprotein (g)B, a surface glycoprotein that has been developed as a HCMV v

218 CD200 (OX-2) is a cell surface glycoprotein that imparts immune privileges by s

219 the LIM-domain factors with axonin1, a cell surface glycoprotein that is a member of the immunoglobu

220 CD24 is a cell surface glycoprotein that is expressed on both immune ce

221 (TF) (CD142) is a 47 kDa transmembrane cell surface glycoprotein that triggers the extrinsic coagula

222 on protein PrP(C) is a Cu(2)(+)-binding cell surface glycoprotein that, when misfolded, is responsibl

223 driven by antigenic changes (drift) in viral surface glycoproteins that allow evasion from preexistin

224 , FRbeta and FRgamma) are cysteine-rich cell-surface glycoproteins that bind folate with high affinit

225 eptors (KIR) are structurally unrelated cell surface glycoproteins that evolved independently to func

226 sion molecules-A, -B, and -C (Jams) are cell surface glycoproteins that have been shown to play an im

227 rogrammed death ligand 1) and PD-L2 are cell-surface glycoproteins that interact with programmed deat

228 patibility (MHC) class II molecules are cell surface glycoproteins that present extracellular antigen

229 y specific carbohydrate moieties on specific surface glycoproteins that serve as receptors for typhoi

230 A and B influenza viruses contain two major surface glycoproteins: the hemagglutinin (HA) and the ne

231 nfluenza viruses bind by their hemagglutinin surface glycoprotein to sialic acid (N-acetylneuraminic

232 Host cell components prime these viral surface glycoproteins to catalyze membrane fusion at spe

233 Enveloped viruses use their surface glycoproteins to catalyze membrane fusion, an es

234 Enveloped viruses utilize transmembrane surface glycoproteins to gain entry into target cells.

235 how that TIV, which is formulated to contain surface glycoproteins to induce serotype-specific antibo

236 oskeleton-associated proteins that link cell surface glycoproteins to the actin cytoskeleton.

237 The cell surface glycoprotein Trask/CDCP1 is phosphorylated durin

238 ody that binds carbonic anhydrase IX, a cell surface glycoprotein ubiquitously expressed in clear cel

239 Its surface glycoproteins undergo proteolytic cleavage and r

240 components are proteases, which cleave viral surface glycoproteins, unleashing them to refold in ways

241 and has a Thr280Ileu mutation in the capsid surface glycoprotein VP7.

242 te's major cell-surface proteins-the variant surface glycoprotein (VSG) and procyclin.

243 ends upon switches in its protective Variant Surface Glycoprotein (VSG) coat by antigenic variation.

244 Variable subregions within the variant surface glycoprotein (VSG) coat displayed by African try

245 se by repeatedly replacing its dense variant surface glycoprotein (VSG) coat from its large genomic V

246 ckness, constantly changes its dense variant surface glycoprotein (VSG) coat to avoid elimination by

247 riation, a periodic switching of its variant surface glycoprotein (VSG) coat.

248 mune system through replacement of a variant surface glycoprotein (VSG) coat.

249 variation by periodic changes in its variant surface glycoprotein (VSG) coat.

250 odies by periodically changing their variant surface glycoprotein (VSG) coat.

251 is protected by an essential coat of Variant Surface Glycoprotein (VSG) comprising approximately 10%

252 ut twenty telomeric bloodstream form Variant Surface Glycoprotein (VSG) expression sites (BESs), of w

253 of the RNA polymerase I transcribed variant surface glycoprotein (VSG) expression sites (ESs) of Try

254 tion is altered at telomere-proximal variant surface glycoprotein (VSG) expression sites (ESs), sugge

255 lation of telomere-proximal silenced variant surface glycoprotein (VSG) expression sites and procycli

256 in the human bloodstream, expresses variant surface glycoprotein (VSG) from 1 of 15 bloodstream expr

257 -I) to transcribe just one telomeric variant surface glycoprotein (VSG) gene at a time, producing sup

258 , Trypanosoma brucei transcribes its variant surface glycoprotein (VSG) gene expression sites (ESs) i

259 RNA polymerase I (Pol I)-transcribed variant surface glycoprotein (VSG) gene expression sites (ESs),

260 cated within the silent subtelomeric variant surface glycoprotein (VSG) gene expression sites, but no

261 rough DNA-repair processes involving Variant Surface Glycoprotein (VSG) gene rearrangements at subtel

262 ression of one of about 20 telomeric variant surface glycoprotein (VSG) gene-expression sites (ESs) w

263 pression and reversible silencing of variant surface glycoprotein (VSG) genes found adjacent to telom

264 Trypanosoma brucei expresses variant surface glycoprotein (VSG) genes in a strictly monoallel

265 rypanosoma brucei is used for moving variant surface glycoprotein (VSG) genes into expression sites d

266 s upon rearrangement of subtelomeric variant surface glycoprotein (VSG) genes to achieve antigenic va

267 expresses one of approximately 1500 variant surface glycoprotein (VSG) genes while multiplying in th

268 can trypanosomes possess hundreds of variant surface glycoprotein (VSG) genes, but only one is expres

269 ution of a massive archive of silent Variant Surface Glycoprotein (VSG) genes, which are activated by

270 ally expresses one of more than 1000 Variant Surface Glycoprotein (VSG) genes.

271 of a repository of telomere-adjacent variant surface glycoprotein (VSG) genes.

272 Th1 cell responses to the variant surface glycoprotein (VSG) of African trypanosomes play

273 The variant surface glycoprotein (VSG) of African trypanosomes, for

274 The variant surface glycoprotein (VSG) of bloodstream form Trypanoso

275 at consists of ten million copies of variant surface glycoprotein (VSG) that is expressed from a sing

276 y switches its major surface antigen variant surface glycoprotein (VSG) to evade mammalian host immun

277 ssing its major surface antigen, the Variant Surface Glycoprotein (VSG), in a monoallelic manner.

278 lies on RNA Pol I for expressing the variant surface glycoprotein (VSG), the key protein in antigenic

279 tem is a dense coat that comprises a variant surface glycoprotein (VSG).

280 hanging their antigenic coat made of variant surface glycoprotein (VSG).

281 densely packed surface monolayer of variant surface glycoprotein (VSG).

282 ching their dense protective coat of Variant Surface Glycoprotein (VSG).

283 sely covered with highly immunogenic Variant Surface Glycoprotein (VSG).

284 directed homologous recombination of Variant Surface Glycoproteins (VSG) genes, most of which reside

285 on due to antigenic variation of the Variant Surface Glycoproteins (VSG) that coat parasites while th

286 eriodically replacing a monolayer of variant surface glycoproteins (VSG) that covers its cell surface

287 arly, defective glycosylation of the variant surface glycoprotein (VSG221) as well as the lysosomal m

288 he sequential expression of distinct variant surface glycoproteins (VSGs) at extremely high density o

289 by periodically expressing different variant surface glycoproteins (VSGs).

290 We found that the surface glycoprotein, VSV-G, was likely the pathogen-ass

291 RSV fusion (F) surface glycoprotein was modified and cloned into a bacu

292 n of bloodstream-form T. brucei, the variant surface glycoprotein, was unaffected in the TbGT8 mutant

293 IF5A in T. brucei in translation of variable surface glycoproteins were also uncovered.

294 Six candidate cell surface glycoproteins were identified.

295 ated by structurally diverse classes of cell-surface glycoproteins, which form homophilic or heteroph

296 The neuraminidase (NA) surface glycoprotein, while diverse, has a conserved enz

297 leased from intracellular organelle and cell surface glycoproteins, while maintaining histopathology

298 Mesothelin is a cell-surface glycoprotein whose expression in normal human ti

299 CD44 and CD24 are important cell surface glycoproteins whose relative expression levels a

300 Interaction of cell surface glycoproteins with endogenous lectins on the cel